Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Incorporated in 1977, Eiko LifeSciences Limited is engaged in the manufacturing, supplying, and export business of Speciality Chemicals and Pharma Intermediates. The company supplies its offerings in India and worldwide.
The products of the company are used in segments like Pharmaceuticals, Agrochemicals, Aroma Chemicals, Electronic Chemicals, and others.
Eiko LifeSciences established a manufacturing unit at MIDC, Badlapur, and has also tied up with many job-workers for manufacturing.
| Issue Open | July 17, 2023 - July 26, 2023 |
| Security Name | Eiko Lifesciences Limited |
| Issue Size (Shares) | 5,544,178 |
| Issue Size (Amount) | ₹24.95 Crores |
| Issue Price | ₹45 per share |
| Face Value | ₹10 per share |
| Listing At | BSE |
| Terms of Payment | The amount of Rs. 13.50 per Rights Equity Share (including premium of Rs. 10.50) is to be paid on the Application. Balance to be paid in not more than two calls as determined by the Board. |
| Entitlement | 2 Rights Equity Share(s) for every 3 fully paid-up Equity Shares held on Record Date |
| Last Date to buy shares | July 6, 2023 |
| Record Date | July 7, 2023 |
| Credit of Rights Entitlements | July 12, 2023 |
| Bid/Offer Opens On | July 17, 2023 |
| Renunciation of Rights Entitlements | July 20, 2023 |
| Bid/Offer Closes On | July 26, 2023 |
| Deemed Date of Allotment | August 3, 2023 |
| Credit Date | August 4, 2023 |
| Listing Date | August 10, 2023 |
| Period Ended | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 31-Mar-21 | 16.61 | 12.45 | 0.61 |
| 31-Mar-22 | 34.89 | 26.09 | 0.71 |
| Amount in ₹ Crore | |||
The Company proposes to utilize the net proceeds from the Issue towards funding the following objects:
2 3.5 Rating:  Vote Here ... |
Eiko Lifesciences Limited
604, Centrum, Opp. TMC Office,
Near Satkar Grande Hotel, Wagle Estate,
Thane - 400604
Phone: 022-2539 0009
Email: investor.relations@eikolifesciences.com
Website: https://www.eikolifesciences.com/
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: rightsissue@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html
The Eiko Lifesciences Rights Issue 2023 opens on July 17, 2023, and closes on July 26, 2023.
Eiko Lifesciences Rights Issue 2023 Schedule
| Last Date for credit of Rights Entitlements | July 12, 2023 |
| Last Date for renunciation of Rights Entitlements | July 20, 2023 |
| Issue Opening Date | July 17, 2023 |
| Issue Closing Date | July 26, 2023 |
| Date of Allotment (on or about) | August 3, 2023 |
| Date of Credit (on or about) | August 4, 2023 |
| Date of Listing (on or about) | August 10, 2023 |
Eiko Lifesciences Rights Issue 2023 price is set at ₹45 per share per equity share.
The eligible shareholders are being offered 2 Rights Equity Share(s) for every 3 fully paid-up Equity Shares held on Record Date (July 7, 2023).
The record date for the Eiko Lifesciences Rights Issue 2023 is July 7, 2023.
The issue size of Eiko Lifesciences Rights Issue 2023 is of 5,544,178 equity shares at ₹45 per share aggregating upto ₹24.95 Crores.
The Letter of Offer for Eiko Lifesciences Rights Issue 2023 can be download here.
You can apply for Eiko Lifesciences Rights Issue 2023 in two ways:
Steps to apply for Eiko Lifesciences Rights Issue 2023 using Net Banking (ASBA)
Note: Your bank may not offer this facility to certain rights issues. In that case, you may have to choose the option below.
Steps to apply for Eiko Lifesciences Rights Issue 2023 using Registrar's website (R-WAP)
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
